According to a market report by Lucintel, the future of the global daptomycin market looks promising with opportunities in the 300mg and 500mg markets. The global daptomycin market is expected to grow with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are increasing population affected by skin and skin structure infections and expanding application as an antibacterial agent, and increasing bloodstream infections, such as sepsis.
A more
than 150-page report to understand trends, opportunity and forecast in
daptomycin market to 2030 by indication (complicated skin structure infections
and bacteremia), age group (pediatric and adult), strength (300mg and 500mg),
and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel
forecasts that complicated skin structure infections will remain the larger
segment over the forecast period due to heightened research and development
initiatives.
Within
this market, 500mg will remain the larger segment due to its efficacy and stability.
Download
sample by clicking on daptomycin market.
North
America will remain the largest over the forecast period due to growing several
government initiatives.
Teva
Pharmaceuticals Industries, Merck, Cipla, Pfizer, BE Pharmaceuticals, Reddy’S
Laboratories, Mylan, Fresenius Kabi, Nichi-Iko Pharmaceutical, Novo Holdings are
the major suppliers in the daptomycin
market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Access Control As A Service Market
Hybrid Memory Cube (HMC) and High-Bandwidth Memory (HBM) Market
No comments:
Post a Comment